1. Home
  2. BBAR vs NVAX Comparison

BBAR vs NVAX Comparison

Compare BBAR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBAR

Banco BBVA Argentina S.A. ADS

HOLD

Current Price

$13.30

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAR
NVAX
Founded
1886
1987
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
1.6B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
BBAR
NVAX
Price
$13.30
$9.44
Analyst Decision
Strong Buy
Hold
Analyst Count
1
9
Target Price
$17.00
$11.33
AVG Volume (30 Days)
672.3K
4.4M
Earning Date
03-04-2026
05-07-2026
Dividend Yield
1.82%
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$12.21
N/A
Revenue Next Year
$13.00
N/A
P/E Ratio
$26.78
$3.77
Revenue Growth
N/A
64.69
52 Week Low
$7.76
$5.01
52 Week High
$23.10
$11.85

Technical Indicators

Market Signals
Indicator
BBAR
NVAX
Relative Strength Index (RSI) 38.98 46.76
Support Level $7.87 $9.14
Resistance Level $17.36 $10.42
Average True Range (ATR) 0.86 0.60
MACD 0.02 -0.13
Stochastic Oscillator 27.99 16.52

Price Performance

Historical Comparison
BBAR
NVAX

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: